6 things to know about new Covid variant XEC
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European Medicines Agency’s (EMA) CHMP for use in individuals aged six months and older.
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Exclusive: Lower levels of protective antibodies could leave the UK population vulnerable to a rapid spread of the XEC Covid ...
Pfizer and BioNTech said on Friday that a committee from the European Medicine Agency recommended marketing authorization for its Omicron adapted vaccine to prevent Covid-19, meaning the vaccine is ...
The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
sub-grandchildren of the original Omicron. So there is still going to be some level of protection there.” Symptoms of XEC ...
COVID levels in the U.S. remain high, according to wastewater detections, which is a retreat from the CDC’s label of “very ...
Now, there’s another new variant getting attention from the infectious disease community. It’s called XEC, and it’s currently ...